Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010:2010:365083.
doi: 10.1155/2010/365083. Epub 2010 May 6.

Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances

Affiliations
Review

Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances

Desmond Yat Hin Yap et al. J Biomed Biotechnol. 2010.

Abstract

Systemic lupus erythematosus (SLE) is a complex auto-immune disorder which involves various facets of the immune system. In addition to autoantibody production and immune complex deposition, emerging evidences suggest that cytokines may act as key players in the immunopathogenesis of SLE. These cytokines assume a critical role in the differentiation, maturation and activation of cells and also participate in the local inflammatory processes that mediate tissue insults in SLE. Certain cytokines such as the IL-6, IL-10, IL-17, BLys, type I interferons (IFN) and tumor necrosis factor-alpha (TNF-alpha) are closely linked to pathogenesis of SLE. The delineation of the role played by these cytokines not only fosters our understanding of this disease but also provides a sound rationale for various therapeutic approaches. In this context, this review focuses on selected cytokines which exert significant effect in the pathogenesis of SLE and their possible clinical applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram to show the complex interaction between various immune cells and cytokines which lead to the pathogenesis of SLE.

References

    1. Hiran T. IL-6 and its receptor. International Reviews of Immunology. 1998;16:249–284. - PubMed
    1. Schimpl A, Wecker E. Replacement of T-cell function by a T-cell product. Nature: New Biology. 1972;237(70):15–17. - PubMed
    1. Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004;13(5):339–343. - PMC - PubMed
    1. Suzuki H, Yasukawa K, Saito T, et al. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. European Journal of Immunology. 1993;23(5):1078–1082. - PubMed
    1. Tang B, Matsuda T, Akira S, et al. Age-associated increase in interleukin 6 in MRL/lpr mice. International Immunology. 1991;3(3):273–278. - PubMed

Publication types